John Branch, MD
Ophthalmology · Cedar Park, TXNPI 1417142977
Payments from drug & device makers
Across 124 payments — averaging $38.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$1K
- Johnson & Johnson Surgical Vision, Inc.$1K
- Rxsight Inc$1K
- Biotissue Holdings Inc.$305
- Carl Zeiss Meditec, Inc.$137
- Mallinckrodt Enterprises LLC$119
- plus $236 from 6 others
What the payments were for
- Speaking & faculty fees$281%
- Travel & lodging$2235%
- Food & beverage$4,48895%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 28 | $1,470 |
| Johnson & Johnson Surgical Vision, Inc. | 45 | $1,422 |
| Rxsight Inc | 32 | $1,050 |
| Biotissue Holdings Inc. | 9 | $305 |
| Carl Zeiss Meditec, Inc. | 1 | $137 |
| Mallinckrodt Enterprises LLC | 1 | $119 |
| Novartis | 1 | $95 |
| Harrow Eye, LLC | 2 | $42 |
| Bausch & Lomb Americas Inc. | 2 | $37 |
| Ivantis, Inc | 1 | $33 |
| Vantage Technology LLC | 1 | $16 |
| Visioneering Technologies, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Tecnis Simplicity$239
- Tecnis IOL$232
- Centurion$142
- AcrySof IQ VIVITY IOL$139
- ARTEVO 800$137
- LUMERA 700$137
- RXSIGHT INJECTOR HANDPIECE$126
- RXSIGHT CONTACT LENS$126
- LIGHT ADJUSTABLE LENS (LAL)$126
- RXSIGHT INJECTOR CARTRIDGE$126
- RXSIGHT LIGHT DELIVERY DEVICE (LDD)$126
- AcrySof IQ PanOptix$120
- ACTHAR$119
- VERITAS Vision System$111
- AcrySof$109
How this compares
$4,739 in reported general payments places this provider in the 70th percentile of 1,355 ophthalmology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LumiganBimatoprost | 28 | $14,753 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 22 | $3,703 |
| Latanoprost | 228 | $2,957 |
| Timolol Maleate | 67 | $1,689 |
| Prednisolone Acetate | 54 | $1,595 |
| Travoprost | 11 | $1,483 |
| Brimonidine Tartrate | 14 | $853 |
| MoxifloxacinMoxifloxacin Hcl | 32 | $809 |
| Diclofenac Sodium | 29 | $268 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Cedar Park
- Vincent RestivoCedar Park$926K
- Charles WykoffBellaire$73.4M
- David BrownHouston$51.7M
- Sunil PatelAbilene$11.1M
- Chirag JhaveriAustin$9.4M
- Robert WongAustin$6.6M
- Fuad MakkoukAustin$6.6M
- Patrick WilliamsArlington$6.6M
- Ashkan AbbeyDallas$5.7M
- Karl CsakyDallas$4.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.